PubRank

B Jasani

Author PubWeight™ 126.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 2000 2.35
2 Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol 2000 2.34
3 Total-body potassium in hypertension patients during prolonged diuretic therapy. Lancet 1972 2.09
4 Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods 2001 2.01
5 A simple post-embedding system for the rapid demonstration of tissue antigens under the electron microscope. Histochem J 1983 1.95
6 Best Practice No 176: Updated recommendations for HER2 testing in the UK. J Clin Pathol 2004 1.90
7 Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am J Clin Pathol 2001 1.89
8 Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 1994 1.88
9 Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2006 1.72
10 High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology 2003 1.64
11 Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol 2000 1.62
12 Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia 2006 1.62
13 Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol 1994 1.52
14 Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine 2007 1.46
15 Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells. Biochem J 1979 1.26
16 Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology 2005 1.25
17 Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Br J Cancer 1995 1.22
18 Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer 1990 1.22
19 HER2 testing in the UK: further update to recommendations. J Clin Pathol 2008 1.22
20 Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax 1996 1.22
21 Studies on the mast cell triggering action of certain artificial histamine liberators. Int Arch Allergy Appl Immunol 1973 1.19
22 Histogenesis of haemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome. J Clin Pathol 1985 1.17
23 Human wound contraction: collagen organization, fibroblasts, and myofibroblasts. Plast Reconstr Surg 1998 1.16
24 Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function. Cell Tissue Res 1999 1.15
25 An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations. Histochem J 1987 1.14
26 Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 1997 1.12
27 Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation. Cancer 1992 1.10
28 Alpha-actinin in nemaline bodies in congenital nemaline myopathy: immunological confirmation by light and electron microscopy. Neuromuscul Disord 1995 1.10
29 Use of monoclonal antihapten antibodies for immunolocalisation of tissue antigens. J Clin Pathol 1981 1.09
30 Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid 2001 1.08
31 A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 2008 1.08
32 Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol 1990 1.07
33 Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. Br J Cancer 2008 1.06
34 Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 1989 1.05
35 The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine 2005 1.04
36 Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Mol Dis 2005 1.04
37 Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma. J Clin Pathol 2001 1.03
38 Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 1993 1.02
39 Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison. Am J Surg Pathol 1994 1.02
40 Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R). Vaccine 2003 1.02
41 Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding. Endocrinology 1984 1.01
42 Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens. Histopathology 2009 1.00
43 Thrombomodulin as a marker of vascular and lymphatic tumours. Histopathology 1996 0.98
44 Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit. Gastroenterology 2001 0.96
45 Metal compound intensification of the electron-density of diaminobenzidine. J Histochem Cytochem 1983 0.96
46 The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis. Acta Neuropathol 1993 0.95
47 Metallothionein expression in human breast cancer. Br J Cancer 1995 0.95
48 Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine 2001 0.95
49 Topical thrombin and control of wound haematoma. Lancet 1977 0.94
50 Factor VIII as a marker of endothelial cells in follicular carcinoma of the thyroid. J Clin Pathol 1983 0.93
51 DNA and enzyme studies on chorionic villi for use in antenatal diagnosis. Clin Chim Acta 1984 0.92
52 Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing. J Clin Pathol 2004 0.92
53 Prophylactic HPV vaccination for women over 18 years of age. Vaccine 2009 0.92
54 Synchronous duodenal neuroendocrine tumours in von Recklinghausen's disease--a case report of co-existing gangliocytic paraganglioma and somatostatin-rich glandular carcinoid. Histopathology 1987 0.90
55 Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Res Treat 1994 0.90
56 Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma. Thorax 1985 0.89
57 Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol 1995 0.89
58 Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch 1994 0.89
59 Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain. Neuropathol Appl Neurobiol 1996 0.88
60 Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM 2003 0.87
61 A system for accurate immunolocalization of Tamm-Horsfall protein in renal biopsies. Histochem J 1985 0.87
62 Molybdenum-associated pituitary endocrinopathy in sheep treated with ammonium tetrathiomolybdate. J Comp Pathol 2004 0.87
63 The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact? J Clin Pathol 2009 0.87
64 Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity. J Neurol Sci 1993 0.86
65 Exploring the use and impact of adjuvant trastuzumab for HER2-positive breast cancer patients in a large UK cancer network. Do the results of international clinical trials translate into a similar benefit for patients in South East Wales? Br J Cancer 2011 0.85
66 High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology 1999 0.85
67 Glandular duodenal carcinoid--a somatostatin rich tumour with neuroendocrine associations. J Clin Pathol 1984 0.85
68 An investigation of the optimal conditions for the in vivo production of immunologically sensitised rat mast cells. J Immunol Methods 1979 0.85
69 Immunohistochemical detection of metallothionein. Methods Enzymol 1991 0.85
70 Immunogold electron-microscopic localisation of calpain I in skeletal muscle of rats. Cell Tissue Res 1986 0.85
71 A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection. J Infect 1996 0.85
72 Immunocytochemical diagnosis of early myocardial ischaemic/hypoxic damage. Forensic Sci Int 1989 0.84
73 Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary. Gynecol Oncol 1988 0.84
74 E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch 1997 0.84
75 Immunocytochemical detection of metallothionein (MT1 and MT2) in copper-enhanced sheep brains. J Comp Pathol 1999 0.84
76 HER2 testing, adjuvant trastuzumab use and results. Our experience in South Wales. Clin Oncol (R Coll Radiol) 2010 0.84
77 Role of calcium chelation in high-temperature antigen retrieval at different pH values. J Pathol 1997 0.83
78 In situ correlation of synthesis and storage of parathormone in parathyroid gland disease. J Pathol 1993 0.83
79 Metallothionein and copper in liver disease with copper retention--a histopathological study. J Pathol 1989 0.82
80 Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. Purinergic Signal 2011 0.82
81 Parathyroid hyperplasia in tertiary hyperparathyroidism: a pathological and immunohistochemical reappraisal. Histopathology 1992 0.82
82 Histochemical and immunocytochemical evaluation of copper and metallothionein in the liver and kidney of copper-loaded rats. J Pathol 1990 0.82
83 Ultimobranchial body nests in human fetal thyroid: an autopsy, histological, and immunohistochemical study in relation to solid cell nests and mucoepidermoid carcinoma of the thyroid. J Pathol 1993 0.82
84 Histological demonstration of immunoreactive zinc metallothionein in liver and ileum of rat and man. Histochem J 1985 0.82
85 Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid. Am J Surg Pathol 1987 0.81
86 p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure. Respir Med 2001 0.81
87 Effect of goitrogen administration on the circadian rhythm of serum thyroid stimulating hormone in the rat. Acta Endocrinol (Copenh) 1981 0.81
88 Non-deleterious dinitrophenyl (DNP) hapten labelling of antibody protein. Preparation and properties of some short-chain DNP imidoesters. J Immunol Methods 1984 0.81
89 Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology 1989 0.81
90 Silver development in microscopy and bioanalysis: past and present. J Pathol 1998 0.80
91 The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma. J Clin Pathol 2002 0.80
92 The use of vimentin antibodies in the diagnosis of malignant mesothelioma. Virchows Arch A Pathol Anat Histopathol 1985 0.80
93 Immunological events leading to destructive thyroiditis in the AUG rat. Clin Exp Immunol 1988 0.80
94 Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and In situ hybridization study. World J Surg 1996 0.80
95 Apoptosis in autoimmune and non-autoimmune thyroid disease. J Pathol 1997 0.80
96 Presence and possible significance of immunohistochemically demonstrable prolactin in breast apocrine metaplasia. Br J Cancer 1987 0.79
97 Immunohistochemical localization of cell surface receptors using a novel method permitting simple, rapid and reliable LM/EM correlation. Histochem J 1986 0.79
98 A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin. Histopathology 1995 0.79
99 Iodination of serum proteins in vivo: relationship to irradiation and hypertrophy of the thyroid. J Endocrinol 1969 0.79
100 The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury. Histochem J 1994 0.78
101 Histological demonstration of immunoreactive metallothionein in rat and human tissues. Experientia Suppl 1987 0.78
102 Metallothionein overexpression in human brain tumours. Acta Neuropathol 1997 0.78
103 The immunocytochemical demonstration of metallothionein in human liver and small intestine. Acta Pharmacol Toxicol (Copenh) 1986 0.78
104 Primary angiosarcoma of the mediastinum: light and electron microscopic demonstration of Factor VIII-related antigen in neoplastic cells. Hum Pathol 1984 0.78
105 Mechanism of impaired glucose tolerance in patients with neoplasia. Br J Cancer 1978 0.78
106 Metallothionein is expressed in adipocytes of brown fat and is induced by catecholamines and zinc. Am J Physiol Regul Integr Comp Physiol 2000 0.78
107 High temperature antigen retrieval and loss of nuclear morphology: a comparison of microwave and autoclave techniques. J Clin Pathol 1996 0.78
108 Simian virus 40 and human pleural mesothelioma. Thorax 1999 0.78
109 Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B. Lab Invest 1995 0.77
110 Metallothionein and copper in liver disease. Lancet 1987 0.77
111 Age-related changes in metallothionein, copper, copper-associated protein, and lipofuscin in human liver: a histochemical and immunohistochemical study. J Pathol 1990 0.77
112 Immunocytochemical identification of metallothionein-positive cells in rheumatoid synovium and analysis of their cell lineage. Histochem J 1997 0.77
113 High-molecular-weight cytokeratin antibody (clone 34betaE12) as a urothelial marker: a note of caution. Histopathology 2004 0.77
114 In vivo photoinduction of metallothionein in human skin by ultraviolet irradiation. J Pathol 1996 0.77
115 Study of childhood renal tumours using a monoclonal antibody to Tamm-Horsfall protein. J Clin Pathol 1987 0.77
116 Parathyroid hyperplasia in multiple endocrine neoplasia type 1: a pathological and immunohistochemical reappraisal. Histopathology 1992 0.77
117 Prostate specific antigen (PSA) and prostate specific acid phosphatase (PSAP) immunoreactivity in benign seminal vesicle\ejaculatory duct epithelium: a potential pitfall in the diagnosis of prostate cancer in needle biopsy specimens. Histopathology 2004 0.77
118 Post-mortem analysis of apoptotic changes associated with human skin bruises. Forensic Sci Int 2000 0.76
119 Clinical studies of human papilloma vaccines in cervical cancer. Adv Exp Med Biol 2001 0.76
120 [Moist autoclaving. A simplified method for antigen unmasking]. Pathologe 1994 0.76
121 Demonstration of reduced in vivo surface expression of activating mutant thyrotrophin receptors in thyroid sections. Eur J Endocrinol 2002 0.76
122 The immunocytochemical demonstration of a relative lack of nerve fibres in the atrioventricular node and bundle of His in the sudden infant death syndrome (SIDS). Forensic Sci Int 1994 0.76
123 Multiple hormone storage by cells of the human pituitary. J Histochem Cytochem 1989 0.75
124 Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining. J Clin Pathol 2004 0.75
125 Non-specific effects of anti-sense oligonucleotides on alpha-1-antitrypsin expression in Cos cells transfected with alpha-1-antitrypsin cDNA constructs. Biochem Soc Trans 1992 0.75
126 Immunohistochemical retrieval of the principal HIV antigens p24, gp41, and gp120 in formalin fixed tissue: an investigation using HIV infected lymphoblasts and postmortem brain tissue from AIDS cases. Mol Pathol 1998 0.75
127 Sensitive system for visualising biotinylated DNA probes hybridised in situ. J Clin Pathol 1986 0.75
128 Epstein-Barr virus in squamous cell carcinoma after renal transplantation. Transplantation 1995 0.75
129 Characterization of two acid proteinases found in rabbit skin homografts. Biochem J 1978 0.75
130 The control of glycerol utilization by glucose metabolism. Biochem J 1972 0.75
131 Endotoxin-induced appearance of peroxidase-positive cells in the white pulp of the mouse spleen. Immunology 1980 0.75
132 Pathology of the spleen in large granular lymphocyte leukaemia. J Clin Pathol 1989 0.75
133 Silver development in microscopy and bioanalysis: a new versatile formulation for modern needs. Histochem J 1998 0.75
134 CA125 in ovarian tumour tissue at second laparotomy. Br J Cancer 1989 0.75
135 Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. No correlation. Virchows Arch 1997 0.75
136 Use of the dinitrophenyl hapten sandwich staining procedure (DHSS) to localize estrogen receptors in paraffin-embedded tissues. J Histochem Cytochem 1991 0.75
137 Non-deleterious inhibition of endogenous peroxidase activity (EPA) by cyclopropanone hydrate: a definitive approach. J Histochem Cytochem 1989 0.75
138 Immunocytochemical diagnosis of early ischaemic/hypoxic damage in myocardium. Acta Med Leg Soc (Liege) 1989 0.75
139 Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomas. J Pathol 1991 0.75
140 The amplification of polymerized diaminobenzidine with physical developers: sensitizing effects of transition metal salts and sulphide. J Microsc 2010 0.75
141 A histochemical and immunocytochemical study of hepatic copper and metallothionein in the pre- and post-natal rat. J Pathol 1991 0.75
142 Tamm-Horsfall protein is a marker of renal and extra-renal rhabdoid tumours. Int J Cancer 1988 0.75
143 Gastrointestinal Richter's syndrome. Hum Pathol 1986 0.75
144 Tamm-Horsfall protein in human renal tumours. Anticancer Res 1992 0.75
145 [Chromogranin A and B and secretogranin II in the endocrine pancreas]. Verh Dtsch Ges Pathol 1987 0.75
146 Triiodothyronine in feces of rats fed low iodine diet. Proc Soc Exp Biol Med 1971 0.75
147 Lack of sampling site variation in chorion villus biopsy as assessed by DNA, enzymatic, morphological and cytogenetical analyses. Prenat Diagn 1987 0.75
148 Wet autoclave pretreatment for immunohistochemical demonstration of oestrogen receptors in routinely processed breast carcinoma tissue. Histochem J 1995 0.75
149 An immunocytochemical method for localization of estrogen receptors in rat tissues using a dinitrophenyl (DNP)-labeled rat monoclonal primary antibody. J Histochem Cytochem 1990 0.75
150 Effect of extrathyroidal activity on the estimation of radioiodide clearance. J Clin Endocrinol Metab 1968 0.75
151 Immunohistochemical detection of metallothionein expression and its correlation with ras activation in melanoma. J Surg Oncol 1994 0.75
152 Immunocytochemically detectable metallothionein in granulation tissue surrounding mucosal ulceration. Histochem J 1992 0.75
153 Histological demonstration of immunoreactive metallothionein in sections of human and rat tissue. Environ Geochem Health 1985 0.75
154 Receptor secretion hypothesis for regulation of hormone action. Med Hypotheses 1983 0.75
155 SV40 DNA sequences in mesotheliomas. Dev Biol Stand 1998 0.75
156 Immortalized human pituitary cells express glycoprotein alpha-subunit and thyrotropin beta (TSH beta). J Clin Endocrinol Metab 1998 0.75
157 Transfection of cos cells by normal and mutant alpha 1-antitrypsin cDNA constructs: biochemical and immunocytochemical findings. Biochem Soc Trans 1990 0.75
158 Immunoelectronmicroscopy: immunogold and immunoperoxidase compared using a new post-embedding system. Med Lab Sci 1984 0.75
159 Pregnancy associated with Gorlin's syndrome. Anaesthesia 1990 0.75
160 Mechanisms of tolerance in the copper-loaded rat liver. Exp Mol Pathol 1993 0.75
161 Metallothionein expression in canine and feline mammary and melanotic tumours. J Comp Pathol 2001 0.75
162 Immunohistochemical identification of prolactin and 24K protein in secretory endometrium. Fertil Steril 1986 0.75
163 Further evaluation of immunocytochemical staining in the diagnosis of early myocardial ischaemic/hypoxic damage. Forensic Sci Int 1990 0.75
164 Light microscopic immunocytochemical demonstration of thyroid-stimulating hormone (TSH) receptors on normal rat thyroid cells. J Histochem Cytochem 1988 0.75
165 Quantitative immunohistochemical evaluation by image analysis of metallothionein in copper-loaded rat kidney. J Histochem Cytochem 1993 0.75
166 Automated cell counting in tissue sections: a new approach by 'multiple grey-level analysis'. J Microsc 1982 0.75
167 Regressing atypical histiocytosis, a regressing cutaneous phase of Ki-1-positive anaplastic large cell lymphoma. Immunocytochemical, nucleic acid, and cytogenetic studies of a new case in view of current opinion. Cancer 1992 0.75
168 Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells. Adv Exp Med Biol 1997 0.75
169 Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence. Mol Cell Endocrinol 2002 0.75
170 Microcalorimetry as a potential tool in the study of antibody--antigen reaction systems incorporating a cellular element. J Immunol Methods 1974 0.75
171 Multiple hormone storage by 'polycrine' cells in the pancreas (from a case of nesidioblastosis). Histochem J 1986 0.75